Yield of urinary tract cancer surveillance among patients with Lynch syndrome
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Genitourinary (GU) cancers are associated with Lynch Syndrome (LS), but surveillance is not consistently recommended or routine. Our aim was to evaluate the yield of urinalysis (UA) and urine cytology-based GU cancer surveillance among LS patients. Methods We conducted a retrospective, single center, registry-based study of LS patients. Demographic characteristics, exposure to GU surveillance, and test performance characteristics were analyzed using descriptive statistics. Results Among 278 LS patients, 36.7% ( n = 102) underwent ≥ 1 GU surveillance episodes. 55.9% ( n = 57) received UA alone and 44.1% ( n = 45) received UA and cytology. 30.4% (31/102) had at least one positive test and three were diagnosed with GU cancer. 178 UAs and 71 urine cytologies were completed. Per test positivity rates were 23.6% for UA, 16.9% for cytology and 36.6% for concurrent testing. Follow-up CT urography and/or cystoscopy occurred after 89% of positive tests. Positive predictive value for GU cancer was 5.6% for UA, 22.2% for cytology and 10% for concurrent testing. False positive rates were 94.4% for UA, 77.8% for cytology and 90% for concurrent testing. Conclusion GU surveillance in LS generates frequent positive tests with many false positives. Although cancers were detected, including at early stages, surveillance strategies require refinement to better balance positivity and yield.
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7236312139
